SurgiQuest, which markets a medical system that enhances access in laparoscopic surgery, filed on Tuesday with the SEC to raise up to $75 million in an initial public offering.
The previous two medical device companies to go public, NovoCure (NVCR) and Penumbra (PEN), trade 9% and 34%, respectively, above their offer prices.
The Milford, CT-based company, which was founded in 2005 and booked $44 million in sales for the 12 months ended September 30, 2015. The company (SRGQ.RC) has not disclosed a ticker or an exchange. SurgiQuest filed confidentially on September 2, 2015. Piper Jaffray and Stifel are the joint bookrunners on the deal. No pricing terms were disclosed.
